Trial watch: Adaptive BATTLE trial uses biomarkers to guide lung cancer treatment.

摘要

A pioneering Phase II trial reported at the American Association for Cancer Research 2010 annual meeting (abstract number LB-1) is the first to demonstrate the use of multiple biomarkers to guide the treatment of patients with non-small cell lung cancer (NSCLC).